{"id":150382,"date":"2014-10-13T21:46:12","date_gmt":"2014-10-14T01:46:12","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/guideline-offers-direction-in-genetic-testing-for-certain-types-of-muscular-dystrophy.php"},"modified":"2014-10-13T21:46:12","modified_gmt":"2014-10-14T01:46:12","slug":"guideline-offers-direction-in-genetic-testing-for-certain-types-of-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/guideline-offers-direction-in-genetic-testing-for-certain-types-of-muscular-dystrophy.php","title":{"rendered":"Guideline offers direction in genetic testing for certain types of muscular dystrophy"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    13-Oct-2014  <\/p>\n<p>    Contact: Rachel Seroka    <a href=\"mailto:rseroka@aan.com\">rseroka@aan.com<\/a>    612-928-6129    American Academy of    Neurology    @GreenJournal<\/p>\n<p>    MINNEAPOLIS  A new guideline from the American Academy of    Neurology (AAN) and the American Association of Neuromuscular    & Electrodiagnostic Medicine (AANEM) recommends guidance on    how doctors should evaluate the full picturefrom symptoms,    family history and ethnicity to a physical exam and certain lab    test resultsin order to determine what genetic tests may best    diagnose a person's subtype of limb-girdle or distal muscular    dystrophy. The guideline is published in the October 14, 2014,    print issue of Neurology, the medical journal of the    American Academy of Neurology. To develop the guideline,    researchers reviewed all of the available studies on the    disorders, which cause muscles to waste away.  <\/p>\n<p>    \"These are rare muscle diseases that can be difficult to    diagnose,\" said guideline lead author Pushpa Narayanaswami, MD,    of Harvard Medical School in Boston and a Fellow of the AAN and    AANEM. \"With an accurate diagnosis, unnecessary tests or    treatments may be avoided. Knowing the specific subtype is    important for getting the best possible care.\"  <\/p>\n<p>    \"Limb girdle\" refers to the hip and shoulder areas, where the    limbs attach to the body. Limb-girdle muscular dystrophy most    affects muscles close to the center of the body, such as in the    areas near the tops of the arms and legs. Distal muscular    dystrophy most affects muscles farther away from the center of    the body, such as muscles in the hands and feet. There are    several known subtypes of limb-girdle muscular dystrophy and    distal muscular dystrophy. Experts continue to discover new    subtypes.  <\/p>\n<p>    Certain signs and symptoms and other information such as family    history can help doctors determine a person's subtype. \"Looking    at a range of clinical signs and symptomssuch as which muscles    are weak and if there is muscle wasting or enlargement, winging    out of the shoulder blades, early signs of contracted limbs,    rigidity of the neck or back, or heart or lung involvementcan    help doctors determine which genetic test to order,\" said    senior author Anthony A. Amato, MD, also of the Harvard Medical    School and a Fellow of the AAN and AANEM. \"This in turn can    shorten the time to diagnosis and start of treatment while    helping avoid more extensive and expensive testing.\"  <\/p>\n<p>    While there is no cure for these disorders, complications can    be managed. The guideline makes recommendations about treating    and managing complications, which may include muscle symptoms,    heart problems and breathing problems.  <\/p>\n<p>    \"Before this publication, there were no care guidelines that    covered both limb-girdle muscular dystrophy and distal MD and    were based on the evidence,\" said Julie Bolen, PhD, MPH, team    lead, National Center on Birth Defects and Developmental    Disabilities, Centers for Disease Control and Prevention (CDC).    \"We hope that this guideline will fill that gap for both the    people who live with these rare disorders and the health care    professionals who treat them.\"  <\/p>\n<p>    The guideline recommends that care for people with these    disorders should be coordinated through treatment centers    specializing in muscular dystrophy. People with these disorders    should tell their doctors about any symptoms such as the heart    beating too fast or skipping beats, shortness of breath and    pain or difficulty in swallowing, as treatments may be    available. People should also talk to their doctors about    exercises that are safe.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Original post:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-10\/aaon-god100914.php\/RK=0\/RS=UgFJjMG11rFl58s5igNSxkR3glg-\" title=\"Guideline offers direction in genetic testing for certain types of muscular dystrophy\">Guideline offers direction in genetic testing for certain types of muscular dystrophy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 13-Oct-2014 Contact: Rachel Seroka <a href=\"mailto:rseroka@aan.com\">rseroka@aan.com<\/a> 612-928-6129 American Academy of Neurology @GreenJournal MINNEAPOLIS A new guideline from the American Academy of Neurology (AAN) and the American Association of Neuromuscular &#038; Electrodiagnostic Medicine (AANEM) recommends guidance on how doctors should evaluate the full picturefrom symptoms, family history and ethnicity to a physical exam and certain lab test resultsin order to determine what genetic tests may best diagnose a person's subtype of limb-girdle or distal muscular dystrophy. The guideline is published in the October 14, 2014, print issue of Neurology, the medical journal of the American Academy of Neurology <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/guideline-offers-direction-in-genetic-testing-for-certain-types-of-muscular-dystrophy.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-150382","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/150382"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=150382"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/150382\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=150382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=150382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=150382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}